Comments

ACADIA Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does ACADIA Pharmaceuticals (ACAD) operate in?

ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ACADNASDAQ

ACADIA Pharmaceuticals (ACAD) Forecast

News Earnings ACADIA Pharmaceuticals (ACAD) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

ACADIA Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:ACAD | Benzinga

Explore ACADIA Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACAD.

Open	$21.46
Close	-
Volume / Avg.	525.91K / 2.06M
Day Range	$21.38 - $21.92
52 Wk Range	13.40 - 25.23
Market Cap	$3.66B
P/E Ratio	15.87
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	15.68%
Days to Cover	4.48

Recent News

JPMorgan Lifts Acadia Price Target After Nuplazid Patent Victory

Acadia wins Nuplazid patent case, extending protection to 2038, as JP Morgan boosts price target ahead of key appeal on the ‘740 COM patent.

Vandana Singh

These Analysts Boost Their Forecasts On Acadia Pharmaceuticals

Avi Kapoor

Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$21.46
Close	-
Volume / Avg.	525.91K / 2.06M
Day Range	$21.38 - $21.92
52 Wk Range	13.40 - 25.23
Market Cap	$3.66B
P/E Ratio	15.87
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	15.68%
Days to Cover	4.48

About Acadia Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commerciali...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ACADIA Pharmaceuticals (ACAD) stock?

You can purchase shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) through any online brokerage.

View our list of the best stock brokerages

Who are ACADIA Pharmaceuticals (ACAD) competitors?

Other companies in ACADIA Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for ACADIA Pharmaceuticals (ACAD) stock?

ACADIA Pharmaceuticals has a consensus price target of $28.09.

What is the current price for ACADIA Pharmaceuticals (ACAD)?

The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $21.89 last updated June 13, 2025 at 2:15 PM EDT.

Does ACADIA Pharmaceuticals (ACAD) pay a dividend?

There are no upcoming dividends for ACADIA Pharmaceuticals.

When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?

ACADIA Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is ACADIA Pharmaceuticals (ACAD) going to split?

There is no upcoming split for ACADIA Pharmaceuticals.

What sector and industry does ACADIA Pharmaceuticals (ACAD) operate in?

ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.